Skip to main content
SpringerLink
Log in

Chemotherapie bei Magenkarzinom

Zweite Linie sinnvoll

Chemotherapy for stomach cancer

Second line makes sense

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Siegel R, Naishadham D, Jemal A (2002) Cancer statistics. CA Cancer J Clin 62:10–29

    Article  Google Scholar 

  2. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150

    Article  PubMed  Google Scholar 

  3. Wagner AD et al (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24:2903–2909

    Article  PubMed  CAS  Google Scholar 

  4. Temel JS et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363:733–742

    Article  PubMed  CAS  Google Scholar 

  5. Thuss-Patience PC et al (2011) Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer—a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Eur J Cancer 47:2306–2314

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Vortragshonorare von Sanofi-Aventis und Pfizer. Forschungsgelder von Sanofi-Aventis.

Author information

Authors and Affiliations

  1. Medizinische Klinik III (Hämatologie und Onkologie), Klinikum Braunschweig, Celler Straße 38, 38114, Braunschweig, Deutschland

    F. Lordick

Authors
  1. F. Lordick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Lordick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lordick, F. Chemotherapie bei Magenkarzinom. Onkologe 18, 543–544 (2012). https://doi.org/10.1007/s00761-012-2278-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-012-2278-y

Search

Navigation